Medicamen Biotech Ltd Share Price

Q: What is the share price of Medicamen Biotech Ltd today?

Medicamen Biotech Ltd share price as on 31 Jan 2025 is ₹459.15

Pharmaceuticals - Indian - Formulations

NSE: MEDICAMEQ Small Cap ISIN: INE646B01010

As on 31 January 2025 at 14:19 IST

₹459.15

-1.95

(-0.42%)

Sell Buy

Over 1 Month

-7.95%

Over 6 Months

5.09%

Over 1 Year

-14.43%

Over 3 Years

-42.93%

Medicamen Biotech Ltd Summary

Close ₹ 459.15

Open ₹ 463.80

High ₹ 470.05

Low ₹ 455.10

Volume 5,029

Net Turnover (in ₹ Cr) ₹ 0.13

52Wk High ₹ 630

52Wk Low ₹ 355.45

52Wk High / Low

355.45

630

Medicamen Biotech Ltd Fundamentals

Key Financial Data

Market Cap (in ₹Cr) ₹ 586.27

EPS (TTM) 8.18

Book Value (BV) 173.40

Div. Yield 0.22 %

P/E (TTM) 56.12

Price/Book Value 2.65

Delivery % 52.37 %

Face Value 10

Key Ratios

PE Ratio 36.63

PB Ratio 2.33

EV to Sales 2.91

PEG Ratio -3.10

ROA 5.52

ROE 6.60

Debt-Equity 0.14

Net Profit Margin 7.72

Operating Profit Margin 17.14

Medicamen Biotech Ltd Financials

Profit and Loss

Consolidated

Standalone

Yearly

Quarterly

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	181.63	143.33	117.17	113.47	127.44
Total Expenses	168.56	126.28	99.07	97.08	109.46
Profit Before Tax	13.08	17.05	18.09	16.39	17.98
Profit After Tax	9.49	14.73	14.90	12.13	13.29
Operating Profit after Depreciation	17.47	19.97	19.50	17.46	18.55

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	91.85	92.66	92.48	89.64	33.69
Total Non Current Assets	134.96	115.15	102.66	97.69	77.15
Total Current Assets	159.59	163.36	123.04	96.03	104.13
TOTAL ASSETS	294.55	278.52	225.69	193.72	181.28
Total Shareholder's Fund	206.98	193.41	146.47	132.89	121.22

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	-6.74	-6.29	4.11	12.77	12.80
Net Cash used in Investing Activities	-5.56	-5.88	-8.47	-17.81	-37.29
Net Cash used in Financing Activities	6.31	29.13	4.30	5.84	19.06

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	174.69	140.35	117.17	110.90	119.25
Total Expenses	157.80	123.01	99.06	94.15	102.65
Profit Before Tax	16.89	17.33	18.10	16.75	16.60
Profit After Tax	13.30	15	14.91	12.49	12.26
Operating Profit after Depreciation	21.27	20.26	19.50	17.82	17.17

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	91.10	92.36	92.48	89.64	33.69
Total Non Current Assets	141.84	118.81	104.72	99.75	79.21
Total Current Assets	152.37	157.97	120.98	92.43	97.24
TOTAL ASSETS	294.21	276.78	225.70	192.18	176.46
Total Shareholder's Fund	209.21	193.80	148.04	134.35	122.48

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	-0.25	-3.50	4.81	12.98	11.71
Net Cash used in Investing Activities	-8.71	-7.54	-8.47	-17.81	-39.35
Net Cash used in Financing Activities	3.14	27.67	4.39	5.68	21.36

Particulars (in ₹ Cr.)	2024-09	2024-06	2024-03	2023-12	2023-09
Total Revenue	44.74	43.05	47.32	46.50	43.54
Total Expenses	39.43	39.60	41.57	41.61	38.90
Profit Before Tax	1.95	1.56	2.66	3.27	2.46
Profit After Tax	0.90	0.80	2.04	2.03	1.48
Operating Profit after Depreciation	5.60	4.04	6.32	5.72	5.19

Particulars (in ₹ Cr.)	2024-09	2024-06	2024-03	2023-12	2023-09
Total Revenue	42.84	41.48	45.01	44.20	42.67
Total Expenses	36.30	36.62	38.19	38.62	36.51
Profit Before Tax	3.25	3.02	3.72	4	4
Profit After Tax	2.27	2.26	3.10	2.77	3.01
Operating Profit after Depreciation	6.83	5.44	7.36	6.41	6.71

Medicamen Biotech Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 452.95

S2 444.80

S3 438.30

Pivot 459.45

R1 467.60

R2 474.10

R3 482.25

Moving Average

20 SMA 482.49

50 SMA 503.77

100 SMA 506.03

200 SMA 484.38

Medicamen Biotech Ltd Corporate Actions

Dividend

Bonus

Splits

Rights

AGM

EGM

Medicamen Biotech Ltd

₹1/Share

Announcement Date 19 Sep 2024

Record Date 19 Sep 2024

Div Yield 10%

AGM Date: 27 Sep 2022

This is to inform that the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2022 were approved by the Board of Directors of the Company at its meeting held today i.e. August 10, 2022. Further details attached. Pursuant to Regulation 30 and 34 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Notice of the 29th Annual General Meeting ('AGM') of the Company scheduled to be held on Tuesday, the 27th day of September, 2022 at 11.00 a.m. (IST) at ISKCON Auditorium, Hare Krishna Hill, Sant Nagar Main Road, East of Kailash, New Delhi-110065, along with the Annual Report of the Company for the Financial Year 2021-2022. The Notice of the AGM and the Annual Report has also been uploaded on the website of the Company at www.medicamen.com . This is for your information and records. (As per BSE Announcement Dated on 3/9/2022) OUTCOME/ SUMMARY OF PROCEEDINGS OF THE 29TH ANNUAL GENERAL MEETING OF MEDICAMEN BIOTECH LIMITED HELD ON 27/09/2022 (As Per BSE Announcement dated on 27.09.2022) Voting Results of 29th Annual General Meeting ('AGM') of Medicamen Biotech Limited held on September 27, 2022 (As per BSE Announcement Dated on 28/9/2022)

AGM Date: 27 Sep 2023

Outcome of the Board Meeting held on August 08, 2023 Outcome/Summary of proceedings of the 30th Annual General Meeting of Medicamen Biotech Limited held on 27.09.2023. (As per BSE Announcement Dated on 27/09/2023)

AGM Date: 26 Sep 2024

AGM 26/09/2024 Book Closure Intimation (As per BSE Announcement Dated on 02/09/2024) We hereby submit the summary of the proceedings of the 31st Annual General Meeting of the Company held on Thursday, September 26, 2024 through Video Conferencing / Other Audio Visual means which commenced at 12.00 PM (IST) and concluded at 01.00 PM (IST). (As Per Bse Announcement Dated on 26.09.2024)

EGM Date: 26 Aug 2022

EGM 26/08/2022 Outcome of Board Meeting held on 01.08.2022 (As Per BSE Announcement Dated on 01.08.2022) In terms of Regulation 30 of Securities and Exchange Board of India ('SEBI') (Listing Obligations and Disclosure Requirement) Regulations, 2015, and other applicable provisions of Listing Regulations, please find enclosed herewith the Notice convening Extraordinary General Meeting ('EGM') of the Company. The Extraordinary General Meeting of the Members of the Company will be held on Friday, August 26, 2022 at 11.00 AM through Video Conferencing (VC) or Other Audio Visual Means (OAVM) in accordance with the aforesaid circulars. (As Per BSE Announcement Dated on 02.08.2022) Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Please find enclose herewith newspaper advertisement cutting for Extra- Ordinary General Meeting along with record dates and details of e-voting information, published in 'The Financial Express and Jansatta'' on 03.08.2022. (As Per BSE Announcement dated on 03.08.2022) In continuation to our intimation dated August 01, 2022, we are submitting herewith the Corrigendum to the notice of Extra Ordinary General Meeting ('EGM') scheduled to be held on Friday, August 26, 2022 at 11:00 a.m. through Video Conferencing / Other Audio-Visual Means. A Corrigendum has been issued to inform the Shareholders of the Company the changes in the explanatory statement as set out for the Item No. 1 and 2, contained in the EGM Notice. Same is enclosed herewith. All other particulars and details as mentioned in the EGM Notice shall remain unchanged. The corrigendum shall be read in conjunction with the EGM Notice dated August 01, 2022 together with explanatory statement. This corrigendum is also available on the Company's website viz. www.medicamen.com. You are requested to take the same on your record. (As Per BSE Announcement Dated on 18.08.2022) The Extraordinary General Meeting ('EGM') of Shareholders of the Company was held on Friday, August 26, 2022, at 11:00 AM and concluded at 11:45 AM through video conferencing/other audio visual means in accordance with the circular(s) issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India in this regard and business(es) mentioned in the Notice dated August 01, 2022, convening the EGM, transacted thereat. In the EGM, the item of business mentioned in the notice was duly considered and discussed. However, the consolidated results of voting at the EGM and remote E-voting opted by the Shareholders will be provided separately, once the report from the scrutinizer will be received. In this regard, please find enclosed herewith, the proceedings of EGM for your information and records. (As Per BSE Announcement Dated on 26.08.2022) In terms of Regulation 44(3) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 (the 'Regulation'), we are furnishing the details of the Remote e-voting and E-voting results at the Extraordinary General Meeting (EGM) of the Company held on August 26, 2022 in the prescribed format. (As Per BSE Announcement Dated on 27.08.2022) Medicamen Biotech Ltd has informed BSE regarding the details of Voting results of EGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. (As Per BSE Announcement dated on 05.09.2022)

Medicamen Biotech Ltd Peer Comparison

Company	Price	Market Cap (in ₹ Cr)
Medicamen Biotech Ltd	₹459.10	₹583.73
Sun Pharmaceuticals Industries Ltd	₹1,745.25	₹4,18,743.94
Divis Laboratories Ltd	₹5,733.60	₹1,52,209.07
Cipla Ltd	₹1,458.15	₹1,17,762.24
Torrent Pharmaceuticals Ltd	₹3,357.15	₹1,13,616.11
Mankind Pharma Ltd	₹2,488.40	₹1,02,663.15

Medicamen Biotech Ltd News

Medicamen Biotech declare Quarterly Result

On 14 November 2024

08 Nov 2024, 12:28 pm

Medicamen Biotech to conduct AGM

On 26 September 2024

13 Sep 2024, 11:43 am

Medicamen Biotech to conduct board meeting

On 13 August 2024

12 Aug 2024, 10:31 am

Board of Medicamen Biotech recommends Final Dividend

Of Rs.1 per share

29 May 2024, 05:32 pm

Medicamen Biotech schedules board meeting

On 29 May 2024

25 May 2024, 03:28 pm

Medicamen Biotech Ltd Stock Analysis

Annual revenue for Medicamen Biotech Ltd increased by 24.47% to ₹174.69 crore in FY 2024 from ₹140.35 crore in FY 2023.
Annual Net Profit for Medicamen Biotech Ltd decreased by 11.36% to ₹13.30 crore in FY 2024 from ₹15 crore in FY 2023.
Promoter Shareholding in Medicamen Biotech Ltd remains unchanged by 0.00% in the most recent quarter, from 42.99% in September 2024 to 42.99% in December 2024.
Medicamen Biotech Ltd delivered a 1-year return of -14.43% compared to the Nifty 50, which provided a return of 8.03% as of the last trading session.
Medicamen Biotech Ltd share price moved down by 0.42% from its previous close of INR ₹461.10. The latest Medicamen Biotech Ltd share price is INR ₹459.15.
Medicamen Biotech Ltd share price today has been at a low of 453.35 and a high of 470.05. Over the past 52 weeks, the Medicamen Biotech Ltd share price has seen a low of 355.45 and a high of 630.